Scientists have made an early but important development in the fight against HIV. 。
For the first time, a team of researchers has shown that they can remove HIV type 1 (HIV-1) from infected mouse cells using a powerful gene-editing tool. By removing DNA of the deadly virus in rodents, they also stopped the virus from replicating.。
While a permanent cure for HIV in humans remains a ways off, the new study is a major step toward achieving that goal, according to scientists at the University of Pittsburgh and Temple University's Lewis Katz School of Medicine.。
SEE ALSO:Scientists see early progress on potential HIV cure。SEE ALSO:Scientists see early progress on potential HIV cure 。 The journal 。 Molecular Therapy 。
published the team's findings on Wednesday.。
Credit: molecular therapy。
For their study, researchers used CRISPR/Cas9, a tool that enables scientists to edit parts of the genome -- our full genetic material -- by removing, adding, or altering sections of the DNA sequence.。
By signing up you agree to our Terms of Use and Privacy Policy.。
Thanks for signing up! 。
The new work builds on an earlier proof-of-concept study that involved genetically modified, or "transgenic," mice and rats. After incorporating the DNA of HIV-1 into the genome of every tissue of the animals' bodies, the team found it could delete targeted fragments of HIV-1 from the genome in most tissues.。
In the first model, researchers again used transgenic mice to confirm their previous findings. The team genetically inactivated HIV-1 in the mice, thus reducing the RNA expression of viral genes by 60 to 95 percent. That means they stopped RNA, which act as a genetic messenger, from relaying the toxic information. 。
A scientist in China worker performs an HIV test at a lab in Shanghai.Credit: china photos/Getty Images 。
For the two other models, scientists studied mice with actively replicating HIV infections and mice with latent infections that lie dormant within the cells. 。
Mice with active infections had EcoHIV, the mouse equivalent of human HIV-1. Using CRISPR/Cas9, researchers were able to block replication of the virus and show they could potentially prevent systemic infection -- marking the first evidence that this method can eradicate the virus. 。
For the latent infections, the team studied "humanized" mice that had been engrafted with human immune cells, including T cells. (People with HIV/AIDS have a devastatingly low number of a particular type of T cell.) The mice were also infected with latent HIV-1. 。
Featured Video For You。
Featured Video For You 。